Stock Price

730,00 CHF

20.5% ROA

25.58% ROE

35.29x PER

Market Cap.

173.676.690,00 CHF

0% DER

2.69% Yield

20.73% NPM

EMS-CHEMIE HOLDING AG Stock Analysis

EMS-CHEMIE HOLDING AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

EMS-CHEMIE HOLDING AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

EMS-CHEMIE HOLDING AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

EMS-CHEMIE HOLDING AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

EMS-CHEMIE HOLDING AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

EMS-CHEMIE HOLDING AG Revenue
Year Revenue Growth
2012 1.785.713.000
2013 1.918.879.000 6.94%
2014 2.002.551.000 4.18%
2015 1.931.901.000 -3.66%
2016 2.011.902.000 3.98%
2017 2.176.569.000 7.57%
2018 2.349.583.000 7.36%
2019 2.209.427.000 -6.34%
2020 1.833.047.000 -20.53%
2021 2.282.733.000 19.7%
2022 2.475.087.000 7.77%
2023 2.366.000.000 -4.61%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

EMS-CHEMIE HOLDING AG Research and Development Expenses
Year Research and Development Expenses Growth
2012 35.887.000
2013 39.962.000 10.2%
2014 44.079.000 9.34%
2015 42.871.000 -2.82%
2016 46.053.000 6.91%
2017 49.693.000 7.32%
2018 53.792.000 7.62%
2019 51.181.000 -5.1%
2020 45.956.000 -11.37%
2021 46.292.000 0.73%
2022 46.646.000 0.76%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

EMS-CHEMIE HOLDING AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

EMS-CHEMIE HOLDING AG EBITDA
Year EBITDA Growth
2012 376.601.000
2013 422.943.000 10.96%
2014 478.924.000 11.69%
2015 525.417.000 8.85%
2016 604.583.000 13.09%
2017 636.029.000 4.94%
2018 675.253.000 5.81%
2019 673.308.000 -0.29%
2020 565.279.000 -19.11%
2021 691.270.000 18.23%
2022 656.834.000 -5.24%
2023 612.000.000 -7.33%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

EMS-CHEMIE HOLDING AG Gross Profit
Year Gross Profit Growth
2012 678.110.000
2013 745.021.000 8.98%
2014 823.178.000 9.49%
2015 838.357.000 1.81%
2016 922.756.000 9.15%
2017 951.757.000 3.05%
2018 1.015.835.000 6.31%
2019 1.002.815.000 -1.3%
2020 855.854.000 -17.17%
2021 1.012.831.000 15.5%
2022 990.770.000 -2.23%
2023 610.000.000 -62.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

EMS-CHEMIE HOLDING AG Net Profit
Year Net Profit Growth
2012 267.890.000
2013 317.618.000 15.66%
2014 342.871.000 7.37%
2015 376.248.000 8.87%
2016 448.755.000 16.16%
2017 481.513.000 6.8%
2018 519.615.000 7.33%
2019 527.140.000 1.43%
2020 434.340.000 -21.37%
2021 550.320.000 21.08%
2022 532.100.000 -3.42%
2023 490.000.000 -8.59%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

EMS-CHEMIE HOLDING AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 11
2013 14 15.38%
2014 15 7.14%
2015 16 12.5%
2016 19 15.79%
2017 21 5%
2018 22 9.09%
2019 23 0%
2020 19 -22.22%
2021 24 21.74%
2022 23 -4.55%
2023 21 -10%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

EMS-CHEMIE HOLDING AG Free Cashflow
Year Free Cashflow Growth
2012 239.171.000
2013 287.224.000 16.73%
2014 437.457.000 34.34%
2015 355.196.000 -23.16%
2016 414.843.000 14.38%
2017 393.520.000 -5.42%
2018 439.513.000 10.46%
2019 489.525.000 10.22%
2020 423.338.000 -15.63%
2021 439.364.999 3.65%
2022 272.010.000 -61.53%
2023 108.000.000 -151.86%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

EMS-CHEMIE HOLDING AG Operating Cashflow
Year Operating Cashflow Growth
2012 282.902.000
2013 344.333.000 17.84%
2014 489.501.000 29.66%
2015 409.641.000 -19.5%
2016 486.038.000 15.72%
2017 442.583.000 -9.82%
2018 499.321.000 11.36%
2019 552.101.000 9.56%
2020 471.530.000 -17.09%
2021 518.313.999 9.03%
2022 365.893.000 -41.66%
2023 124.000.000 -195.08%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

EMS-CHEMIE HOLDING AG Capital Expenditure
Year Capital Expenditure Growth
2012 43.731.000
2013 57.109.000 23.43%
2014 52.044.000 -9.73%
2015 54.445.000 4.41%
2016 71.195.000 23.53%
2017 49.063.000 -45.11%
2018 59.808.000 17.97%
2019 62.576.000 4.42%
2020 48.192.000 -29.85%
2021 78.949.000 38.96%
2022 93.883.000 15.91%
2023 16.000.000 -486.77%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

EMS-CHEMIE HOLDING AG Equity
Year Equity Growth
2012 1.138.167.000
2013 1.199.312.000 5.1%
2014 1.268.211.000 5.43%
2015 1.311.806.000 3.32%
2016 1.427.781.999 8.12%
2017 1.550.410.000 7.91%
2018 1.644.662.000 5.73%
2019 1.685.645.000 2.43%
2020 1.624.250.000 -3.78%
2021 1.828.327.000 11.16%
2022 1.844.389.000 0.87%
2023 2.057.000.000 10.34%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

EMS-CHEMIE HOLDING AG Assets
Year Assets Growth
2012 1.660.986.000
2013 1.737.852.000 4.42%
2014 1.845.626.000 5.84%
2015 1.890.973.000 2.4%
2016 1.984.624.000 4.72%
2017 2.099.998.999 5.49%
2018 2.157.617.000 2.67%
2019 2.213.309.000 2.52%
2020 2.077.534.999 -6.54%
2021 2.324.676.000 10.63%
2022 2.316.000.000 -0.37%
2023 2.459.000.000 5.82%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

EMS-CHEMIE HOLDING AG Liabilities
Year Liabilities Growth
2012 522.818.999
2013 538.540.000 2.92%
2014 577.415.000 6.73%
2015 579.167.000 0.3%
2016 556.842.000 -4.01%
2017 549.589.000 -1.32%
2018 512.955.000 -7.14%
2019 527.664.000 2.79%
2020 453.285.000 -16.41%
2021 496.349.000 8.68%
2022 471.611.000 -5.25%
2023 402.000.000 -17.32%

EMS-CHEMIE HOLDING AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
101.5
Net Income per Share
21.04
Price to Earning Ratio
35.29x
Price To Sales Ratio
0.07x
POCF Ratio
37.04
PFCF Ratio
0.45
Price to Book Ratio
8.55
EV to Sales
-0.02
EV Over EBITDA
-0.09
EV to Operating CashFlow
-0.12
EV to FreeCashFlow
-0.15
Earnings Yield
0.03
FreeCashFlow Yield
2.22
Market Cap
0,17 Bil.
Enterprise Value
-0,06 Bil.
Graham Number
202.75
Graham NetNet
16.4

Income Statement Metrics

Net Income per Share
21.04
Income Quality
0.95
ROE
0.26
Return On Assets
0.2
Return On Capital Employed
0.26
Net Income per EBT
0.89
EBT Per Ebit
0.98
Ebit per Revenue
0.24
Effective Tax Rate
0.11

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0.24
Pretax Profit Margin
0.23
Net Profit Margin
0.21

Dividends

Dividend Yield
0.03
Dividend Yield %
2.69
Payout Ratio
0.78
Dividend Per Share
20

Operating Metrics

Operating Cashflow per Share
20.05
Free CashFlow per Share
16.46
Capex to Operating CashFlow
-0.18
Capex to Revenue
-0.04
Capex to Depreciation
-1.81
Return on Invested Capital
0.25
Return on Tangible Assets
0.2
Days Sales Outstanding
54.43
Days Payables Outstanding
17.31
Days of Inventory on Hand
89.31
Receivables Turnover
6.71
Payables Turnover
21.09
Inventory Turnover
4.09
Capex per Share
-3.59

Balance Sheet

Cash per Share
9,88
Book Value per Share
86,84
Tangible Book Value per Share
85.47
Shareholders Equity per Share
86.84
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-0.38
Current Ratio
5.59
Tangible Asset Value
2,00 Bil.
Net Current Asset Value
1,32 Bil.
Invested Capital
0
Working Capital
1,41 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,35 Bil.
Average Payables
0,11 Bil.
Average Inventory
578000000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

EMS-CHEMIE HOLDING AG Dividends
Year Dividends Growth
2006 7
2012 7 14.29%
2013 10 30%
2014 11 9.09%
2015 12 8.33%
2016 15 20%
2017 17 11.76%
2022 21 19.05%
2023 20 -5%

EMS-CHEMIE HOLDING AG Profile

About EMS-CHEMIE HOLDING AG

EMS-CHEMIE HOLDING AG engages in the high performance polymers and specialty chemicals businesses worldwide. The company's High Performance Polymers segment is involved in the manufacture and supply of high-performance polyamides granulates. Its Specialty Chemicals segment develops, produces, and sells fibers, bonding agent for tires, fusible adhesives, and adhesive yarns for technical and textile applications; powder coatings; and reactive diluents. The company also offers bonding, coating, sealing, and damping systems; and hotmelt adhesives, crosslinkers, epoxy systems, technical fibers, adhesion promoters, and fusible bonding yarns and granules. It serves automotive, electro and electronic, industry and consumer goods, optic, and packaging markets. The company was founded in 1936 and is based in Domat/Ems, Switzerland. EMS-CHEMIE HOLDING AG is a subsidiary of EMESTA HOLDING AG.

CEO
Ms. Magdalena Martullo-Bloche
Employee
2.736
Address
Via Innovativa 1
Domat/Ems, 7013

EMS-CHEMIE HOLDING AG Executives & BODs

EMS-CHEMIE HOLDING AG Executives & BODs
# Name Age
1 Mr. Peter Germann
Member of Executive Management
70
2 Mr. Oliver Minger
Chief Financial Officer & Member of Executive Management
70
3 Mr. Urs Janssen
Member of Executive Management
70
4 Ms. Magdalena Martullo-Blocher
Vice-Chairman, Chief Executive Officer & Member of Executive Management
70
5 Dr. Christoph Kleiner
Member of Management Board
70

EMS-CHEMIE HOLDING AG Competitors